Company Filing History:
2 out of 22 
2 out of 5,089 
2 out of 4 Years Active: 2010-2014
Title: **Aline Moulin: Innovator in Ghrelin Receptor Research**
Introduction
Aline Moulin is a distinguished inventor based in Portes-les-Valence, France, known for her contributions to the field of biochemistry and pharmacology. With a focus on ghrelin analogue ligands and their implications in treating various physiological conditions, Moulin holds two patents that showcase her innovative approach to medical science.
Latest Patents
Moulin's latest patents involve novel triazole derivatives that serve as ghrelin analogue ligands of growth hormone secretagogue receptors. These inventions are pivotal for the treatment and prophylaxis of conditions mediated by GHS receptors, particularly in mammals and humans. The patents detail the efficacy of these compounds in issues such as growth retardation, cachexia, and various metabolic disorders including obesity and diabetes types I and II. Furthermore, her inventions explore the modulation of GHS receptor activity, providing therapeutic options for conditions like inflammation and postoperative complications.
Career Highlights
Throughout her career, Aline Moulin has accumulated experience working with reputable organizations. Notably, she has worked at Zentaris GmbH and the National Center for Scientific Research (Centre National De La Recherche Scientifique). Her roles in these institutions have allowed her to advance her research in biopharmaceuticals, leading to her significant patent contributions.
Collaborations
Moulin has collaborated with notable colleagues, including Daniel Perrissoud and Jean Martinez. These partnerships have enriched her research and fostered a collaborative environment that enhances innovation in pharmaceutical development.
Conclusion
Aline Moulin stands as a testament to the impact of innovative thinking in the realm of biochemistry. Her patents not only reflect her dedication to advancing medical science but also her ability to collaborate effectively within the research community. As she continues to develop groundbreaking solutions to complex health issues, her work will undoubtedly contribute to the future of pharmaceutical advancements.